Day One Biopharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
178
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.5B
- Investors
-
1
Day One Biopharmaceuticals General Information
Description
Developer of targeted oncology therapies intended to treat patients with genetically defined cancers. The company's platform utilizes a search and development strategy to advance oral, brain-penetrant kinase inhibitors and antibody-drug conjugates, enabling healthcare providers to treat pediatric and adult patients living with low-grade gliomas and various solid tumors.
Contact Information
Website
www.dayonebio.com(Operating Subsidiary)
Corporate Office
- 1800 Sierra Point Parkway
- Suite 200
- Brisbane, CA 94005
- United States
Corporate Office
- 1800 Sierra Point Parkway
- Suite 200
- Brisbane, CA 94005
- United States
Day One Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 23-Apr-2026 | $2.5B | Completed | Generating Revenue | ||
| 6. PIPE | 01-Aug-2024 | Completed | Generating Revenue | |||
| 5. 2PO | 07-Jun-2023 | Completed | Generating Revenue | |||
| 4. 2PO | 15-Jun-2022 | Completed | Generating Revenue | |||
| 3. IPO | 27-May-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Feb-2021 | $130M | $190M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 21-May-2020 | $60M | $60M | Completed | Generating Revenue |
Day One Biopharmaceuticals Comparisons
Industry
Financing
Details
Day One Biopharmaceuticals Competitors (6)
One of Day One Biopharmaceuticals’s 6 competitors is Lite Strategy, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lite Strategy | Corporation | San Diego, CA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Xynomic Pharmaceuticals | Formerly VC-backed | Poway, CA |
Day One Biopharmaceuticals Patents
Day One Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024381999-A1 | Methods of treating pediatric low-grade glioma | Pending | 15-Nov-2023 | ||
| EP-4808559-A1 | Methods of treating pediatric low-grade glioma | Pending | 15-Nov-2023 | ||
| WO-2025106686-A1 | Methods of treating pediatric low-grade glioma | Inactive | 15-Nov-2023 | ||
| AU-2023272583-A1 | Oral liquid suspension of pan-raf kinase inhibitor | Pending | 16-May-2022 | ||
| EP-4525876-A1 | Oral liquid suspension of pan-raf kinase inhibitor | Pending | 16-May-2022 | A61K9/10 |
Day One Biopharmaceuticals Signals
Day One Biopharmaceuticals Former Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Boxer Capital | Corporate Venture Capital | Minority | ||
| Braidwell | Hedge Fund | Minority | ||
| Canaan Partners | Venture Capital | Minority |
Day One Biopharmaceuticals Acquisitions (1)
Day One Biopharmaceuticals’s most recent deal was a Merger/Acquisition with Mersana Therapeutics for . The deal was made on 06-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mersana Therapeutics | 06-Jan-2026 | Merger/Acquisition | Drug Discovery |
Day One Biopharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.09 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Day One Biopharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Mersana Therapeutics | Cambridge, MA | 2001 |
Day One Biopharmaceuticals FAQs
-
When was Day One Biopharmaceuticals founded?
Day One Biopharmaceuticals was founded in 2018.
-
Where is Day One Biopharmaceuticals headquartered?
Day One Biopharmaceuticals is headquartered in Brisbane, CA.
-
What is the size of Day One Biopharmaceuticals?
Day One Biopharmaceuticals has 178 total employees.
-
What industry is Day One Biopharmaceuticals in?
Day One Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Day One Biopharmaceuticals a private or public company?
Day One Biopharmaceuticals is a Private company.
-
What is the current valuation of Day One Biopharmaceuticals?
The current valuation of Day One Biopharmaceuticals is .
-
What is Day One Biopharmaceuticals’s current revenue?
The current revenue for Day One Biopharmaceuticals is .
-
How much funding has Day One Biopharmaceuticals raised over time?
Day One Biopharmaceuticals has raised $825M.
-
Who are Day One Biopharmaceuticals’s investors?
Atlas Venture, BVF Partners, Boxer Capital, Braidwell, and Canaan Partners are 5 of 17 investors who have invested in Day One Biopharmaceuticals.
-
Who are Day One Biopharmaceuticals’s competitors?
Lite Strategy, Kite Pharma, CytomX Therapeutics, Aura Biosciences, and Xynomic Pharmaceuticals are some of the 6 competitors of Day One Biopharmaceuticals.
-
When was Day One Biopharmaceuticals acquired?
Day One Biopharmaceuticals was acquired on 23-Apr-2026.
-
Who acquired Day One Biopharmaceuticals?
Day One Biopharmaceuticals was acquired by Servier.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process